Strengthening Tourette Treatment OPtions Using TMS to Improve CBIT, a Double-blind, Randomized, Controlled Study (STOP-TIC)
Primary Purpose
Tourette Syndrome
Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
transcranial magnetic stimulation
Sponsored by
About this trial
This is an interventional treatment trial for Tourette Syndrome focused on measuring Tourette Syndrome, Comprehensive Behavioral Intervention for Tics, Transcranial Magnetic Stimulation
Eligibility Criteria
Inclusion Criteria: Age 18 years or older Diagnosis of Tourette Syndrome Moderate Tic Severity at baseline Exclusion Criteria: Presence of metallic objects or neurostimulators in the brain Pregnancy History of active seizures or epilepsy Contraindications to receiving fMRI Inability to participate in CBIT due to other underlying cognitive or medical condition
Sites / Locations
- WVU RNIRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Sham Comparator
Arm Label
Active rTMS
Sham rTMS
Arm Description
Patients receiving active rTMS
Patients receiving sham rTMS
Outcomes
Primary Outcome Measures
Yale Global Tic Severity Scale (YGTSS)
Tic severity will be measured with YGTSS. YGTSS is a clinician-rated scale used to assess tic severity, scored out of 100 where a higher score indicates greater tic frequency and severity. It includes a checklist of motor and vocal tics followed by an assessment of the number, frequency, intensity, complexity, and inference of motor tics and phonic tics - scored separately. Each of these dimensions is scored on a 0 to 5 scale. The YGTSS provides three tic severity scores: Total Motor (0 to 25); Total Phonic (0 to 25) and the combined Total Tic Severity Score (0 to 50), as well as a separate Impairment dimension scored from 0 to 50.
Modified Rush Videotape Tic Rating Scale (mRVTRS)
This is a tool used by an objective examiner to quantify the severity of a patient's tics by rating the number of body areas affected, motor tic frequency, phonic tic frequency, motor tic severity, and phonic tic severity, each on a 0 through 4 score by watching a video of the patient. Scored out of 20, where a higher score indicates greater tic severity.
Secondary Outcome Measures
Full Information
NCT ID
NCT05705999
First Posted
January 21, 2023
Last Updated
July 24, 2023
Sponsor
West Virginia University
Collaborators
University of Florida, Tourette Association of America
1. Study Identification
Unique Protocol Identification Number
NCT05705999
Brief Title
Strengthening Tourette Treatment OPtions Using TMS to Improve CBIT, a Double-blind, Randomized, Controlled Study
Acronym
STOP-TIC
Official Title
Strengthening Tourette Treatment OPtions Using TMS to Improve CBIT, a Double-blind, Randomized, Controlled Study
Study Type
Interventional
2. Study Status
Record Verification Date
July 2023
Overall Recruitment Status
Recruiting
Study Start Date
August 2023 (Anticipated)
Primary Completion Date
March 30, 2025 (Anticipated)
Study Completion Date
March 30, 2025 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
West Virginia University
Collaborators
University of Florida, Tourette Association of America
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This pilot study will investigate the clinical and neurophysiological effects of repetitive transcranial magnetic stimulation (rTMS) followed by comprehensive behavioral intervention for tics (CBIT) in adult patients with Tourette's Syndrome (TS). Two groups of moderate disease severity will be randomized to receive active or sham rTMS targeted to the supplementary motor area (SMA) followed by eight CBIT sessions. The change in tic frequency and severity (primary outcome) and neurophysiological changes (secondary outcome) will be compared between the two groups. The central hypothesis is that low frequency rTMS will augment the effects of CBIT through favorable priming of the SMA network.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Tourette Syndrome
Keywords
Tourette Syndrome, Comprehensive Behavioral Intervention for Tics, Transcranial Magnetic Stimulation
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
20 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Active rTMS
Arm Type
Active Comparator
Arm Description
Patients receiving active rTMS
Arm Title
Sham rTMS
Arm Type
Sham Comparator
Arm Description
Patients receiving sham rTMS
Intervention Type
Device
Intervention Name(s)
transcranial magnetic stimulation
Intervention Description
The neurostimulation protocol will include 1-Hz rTMS over the bilateral SMA at 110% RMT. The SMA will be identified as 4 cm anterior to the vertex (Cz in standard 10-20 EEG setup). Each session will consist of 6 trains lasting 5 minutes each (300 pulses per train) with an intertrain interval of 1 minute for a total duration of 35 minutes (1800 pulses). Patients will receive 4 sessions each day on 4 consecutive days for a total of 16 sessions. Daily duration of this study protocol should last approximately 170 minutes including a 10-minute break in between each session
Primary Outcome Measure Information:
Title
Yale Global Tic Severity Scale (YGTSS)
Description
Tic severity will be measured with YGTSS. YGTSS is a clinician-rated scale used to assess tic severity, scored out of 100 where a higher score indicates greater tic frequency and severity. It includes a checklist of motor and vocal tics followed by an assessment of the number, frequency, intensity, complexity, and inference of motor tics and phonic tics - scored separately. Each of these dimensions is scored on a 0 to 5 scale. The YGTSS provides three tic severity scores: Total Motor (0 to 25); Total Phonic (0 to 25) and the combined Total Tic Severity Score (0 to 50), as well as a separate Impairment dimension scored from 0 to 50.
Time Frame
Through study completion, an average of 3 months
Title
Modified Rush Videotape Tic Rating Scale (mRVTRS)
Description
This is a tool used by an objective examiner to quantify the severity of a patient's tics by rating the number of body areas affected, motor tic frequency, phonic tic frequency, motor tic severity, and phonic tic severity, each on a 0 through 4 score by watching a video of the patient. Scored out of 20, where a higher score indicates greater tic severity.
Time Frame
Through study completion, an average of 3 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
100 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age 18 years or older
Diagnosis of Tourette Syndrome
Moderate Tic Severity at baseline
Exclusion Criteria:
Presence of metallic objects or neurostimulators in the brain
Pregnancy
History of active seizures or epilepsy
Contraindications to receiving fMRI
Inability to participate in CBIT due to other underlying cognitive or medical condition
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jessica Frey, MD
Phone
304-598-6127
Email
Jessica.frey@hsc.wvu.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jessica Frey, MD
Organizational Affiliation
WVU RNI
Official's Role
Principal Investigator
Facility Information:
Facility Name
WVU RNI
City
Morgantown
State/Province
West Virginia
ZIP/Postal Code
26506
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jessica Frey, MD
Phone
304-598-6127
Email
Jessica.frey@hsc.wvu.edu
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Strengthening Tourette Treatment OPtions Using TMS to Improve CBIT, a Double-blind, Randomized, Controlled Study
We'll reach out to this number within 24 hrs